REVIEW
Published on 15 May 2020
PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
doi 10.3389/fphar.2020.00722
- 24,800 views
- 75 citations
- Frontiers in Pharmacology
- Drugs Outcomes Research and Policies
- Research Topics
- Evidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer
Evidence-based Advance and Management of Adverse Events of Immunotherapy for Cancer
34k
Total Downloads
128k
Total Views and Downloads
Submit your idea
You will be redirected to our submission process.
Articles
SYSTEMATIC REVIEW
Published on 14 Feb 2020
Comparative Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Advanced Cancer: A Systematic Review and Meta-Analysis
doi 10.3389/fphar.2020.00040
- 8,349 views
- 44 citations
ORIGINAL RESEARCH
Published on 10 Jan 2020
Comprehensive Survey of Clinical Trials Registration for Melanoma Immunotherapy in the ClinicalTrials.gov
doi 10.3389/fphar.2019.01539
- 2,524 views
- 6 citations
REVIEW
Published on 29 Nov 2019
PD-1 Inhibitors in the Advanced Esophageal Cancer
doi 10.3389/fphar.2019.01418
- 8,060 views
- 31 citations
REVIEW
Published on 29 Nov 2019
Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management
doi 10.3389/fphar.2019.01350
- 10,814 views
- 85 citations
SYSTEMATIC REVIEW
Published on 04 Nov 2019
Antitumor Activity and Treatment-Related Toxicity Associated With Nivolumab Plus Ipilimumab in Advanced Malignancies: A Systematic Review and Meta-Analysis
doi 10.3389/fphar.2019.01300
- 2,542 views
- 15 citations
SYSTEMATIC REVIEW
Published on 24 Oct 2019
The Differences in the Safety and Tolerability of Immune Checkpoint Inhibitors as Treatment for Non–Small Cell Lung Cancer and Melanoma: Network Meta-Analysis and Systematic Review
doi 10.3389/fphar.2019.01260
- 5,926 views
- 22 citations
REVIEW
Published on 23 Oct 2019
Immune Checkpoint Inhibitor Toxicity in Head and Neck Cancer: From Identification to Management
doi 10.3389/fphar.2019.01254
- 4,036 views
- 27 citations
SYSTEMATIC REVIEW
Published on 17 Oct 2019
Adverse Events of Concurrent Immune Checkpoint Inhibitors and Antiangiogenic Agents: A Systematic Review
doi 10.3389/fphar.2019.01173
- 3,944 views
- 43 citations
REVIEW
Published on 11 Oct 2019
Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
doi 10.3389/fphar.2019.01184
- 7,398 views
- 57 citations
ORIGINAL RESEARCH
Published on 24 Sep 2019
The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
doi 10.3389/fphar.2019.01100
- 4,170 views
- 10 citations
SYSTEMATIC REVIEW
Published on 23 Sep 2019
The Relative Risk of Immune-Related Liver Dysfunction of PD-1/PD-L1 Inhibitors Versus Chemotherapy in Solid Tumors: A Meta-Analysis of Randomized Controlled Trials
doi 10.3389/fphar.2019.01063
- 3,069 views
- 8 citations
Published in
Frontiers in Pharmacology
- Drugs Outcomes Research and Policies
Impact
- 128kTopic views
- 89kArticle views
- 34kArticle downloads